Outcomes of patients with metastatic clear-cell renal cell carcinoma treated with pazopanib after progression during treatment with other targeted therapies

Podobne knjige/članki

• Outcomes of Unselected Patients with Metastatic Clear-Cell Renal Cell Carcinoma Treated with Front-Line Pazopanib Therapy Followed by Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors (VEGFR-TKI) or Mammalian Target of Rapamycin Inhibitors (mTORi): A Single Institution Experience
  od: Matrana, Marc R., et al.
  Izdano: (2015)
• Outcomes of Patients With Metastatic Renal Cell Carcinoma and End-Stage Renal Disease Receiving Dialysis and Targeted Therapies: A Single Institution Experience
  od: Shetty, Aditya V., et al.
  Izdano: (2014)
• Systemic Therapy for Metastatic Non-Clear Cell Renal Cell Carcinoma: Recent Progress and Future Directions
  od: Chowdhury, Simon, et al.
  Izdano: (2011)
• Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy
  od: Richey, S. L., et al.
  Izdano: (2011)
• Challenges in the long-term management of patients with metastatic renal cell carcinoma treated with targeted therapy: Optimizing surgery, systemic therapy and quality of life
  od: Jonasch, Eric, et al.
  Izdano: (2010)